This patient has diphtheria, caused by Corynebacterium diphtheriae. The potent diphtheria toxin causes cell death by ADP-ribosylation and inactivation of elongation factor-2 (EF-2), which halts protein synthesis. The heart and neural tissues are particularly susceptible, leading to complications like myocarditis and neuropathy.

The patient has cholera, caused by Vibrio cholerae. Cholera toxin is an A-B toxin that ADP-ribosylates the Gs α-subunit of the G protein complex in intestinal epithelial cells. This locks Gs in an active state, leading to constitutive activation of adenylate cyclase, a dramatic increase in intracellular cAMP, and subsequent secretion of Cl-, Na+, and water into the intestinal lumen.

This patient has foodborne botulism from Clostridium botulinum. The botulinum toxin is a protease that cleaves SNARE proteins in presynaptic motor neurons, preventing the release of acetylcholine into the synaptic cleft at the neuromuscular junction. This leads to a flaccid paralysis. In contrast, tetanus toxin acts on inhibitory neurons in the CNS.

The patient has Clostridioides difficile infection. The primary virulence factors are Toxin A (an enterotoxin) and Toxin B (a cytotoxin). Both toxins inactivate Rho-family GTPases by glycosylation. This disrupts the actin cytoskeleton, leading to loss of tight junction integrity, inflammation, apoptosis, and the formation of the characteristic pseudomembranes.

This patient has hemolytic uremic syndrome (HUS) caused by Shiga-like toxin from enterohemorrhagic E. coli (EHEC), often serotype O157:H7. Shiga toxin (and Shiga-like toxin) is an A-B toxin that inactivates protein synthesis by cleaving a specific adenine residue in the 28S rRNA of the 60S ribosomal subunit. This is particularly damaging to glomerular endothelial cells, leading to microthrombi formation, renal failure, and HUS.

The patient has pneumococcal pneumonia caused by Streptococcus pneumoniae. The single most important virulence factor for S. pneumoniae is its thick polysaccharide capsule. The capsule has antiphagocytic properties, preventing opsonization and engulfment by macrophages and neutrophils, thereby allowing the organism to multiply in the alveoli and cause invasive disease. While S. pneumoniae does produce an IgA protease, the capsule is the key factor for evading phagocytosis.

The clinical picture describes an infection with Staphylococcus aureus. A key immune evasion virulence factor of S. aureus is Protein A, a surface protein that binds to the Fc (constant) region of IgG antibodies. This binding effectively coats the bacterium with host antibodies in an inverted orientation, which blocks the Fab regions from binding to the bacterium and prevents the Fc regions from being recognized by phagocyte Fc receptors, thus inhibiting opsonization and phagocytosis.

The infant has pertussis (whooping cough), caused by Bordetella pertussis. Pertussis toxin ADP-ribosylates and inactivates the inhibitory G protein, Giα. This prevents Gi from inhibiting adenylate cyclase, leading to an unregulated increase in intracellular cAMP levels. This disrupts cellular signaling and contributes to the characteristic lymphocytosis by preventing lymphocytes from entering lymphoid tissue.

Staphylococcal scalded skin syndrome (SSSS) is caused by the exfoliative toxins (ETA, ETB) produced by Staphylococcus aureus. These toxins are proteases that specifically cleave desmoglein-1, a cadherin protein essential for cell-to-cell adhesion within the desmosomes of the stratum granulosum of the epidermis. This cleavage leads to intraepidermal separation, blistering, and the characteristic Nikolsky sign.

The patient likely has an infection with Neisseria gonorrhoeae. To survive on mucosal surfaces, this bacterium, along with Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, produces an IgA protease. This enzyme cleaves secretory IgA at its hinge region, inactivating it and allowing the bacteria to adhere to and penetrate the mucosal epithelium without being trapped in mucus.